Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.

Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.

Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Chief Medical Officer | Jamil Khurram | Jul 14, 2026 | Sell | $83.28K | 16,250 |
| Director | Shlevin Harold H. | Jun 29, 2026 | Sell | $112.23K | 22,268 |
| Chief Medical Officer | Jamil Khurram | Jun 29, 2026 | Sell | $239.23K | 47,467 |
| Director | Shlevin Harold H. | Jun 26, 2026 | Sell | $38.66K | 7,732 |
| Chief Medical Officer | Jamil Khurram | Jun 26, 2026 | Sell | $10.19K | 2,037 |
| Chief Medical Officer | Jamil Khurram | Jun 26, 2026 | Sell | $12.67K | 2,533 |
| Chief Medical Officer | Jamil Khurram | Jun 23, 2026 | Sell | $23.73K | 7,557 |
| Chief Medical Officer | Jamil Khurram | May 26, 2026 | Sell | $1.76K | 568 |
| Director | ELDRED KARY | Feb 6, 2026 | Buy | $810 | 300 |
| Chief Medical Officer | Jamil Khurram | Jan 6, 2026 | Sell | $78.2K | 21,446 |
| CEO | LEWIS JOEL | Jan 6, 2026 | Sell | $134.85K | 37,698 |
| CFO | CALLICUTT JACK W | Jan 6, 2026 | Sell | $74.7K | 20,354 |
| CEO | LEWIS JOEL | Jan 5, 2026 | Sell | $108.34K | 27,731 |
| Chief Medical Officer | Jamil Khurram | Jan 5, 2026 | Sell | $99.41K | 25,499 |
| CFO | CALLICUTT JACK W | Jan 5, 2026 | Sell | $100.3K | 25,732 |
| CEO | LEWIS JOEL | Jan 2, 2026 | Sell | $77.94K | 18,571 |
| Chief Medical Officer | Jamil Khurram | Jan 2, 2026 | Sell | $54.79K | 13,055 |
| CFO | CALLICUTT JACK W | Jan 2, 2026 | Sell | $58.39K | 13,914 |
| Chief Medical Officer | Jamil Khurram | Dec 31, 2025 | Sell | $33.09K | 8,125 |
| Director | FREEMAN KEVIN D | Dec 23, 2025 | Buy | $19.51K | 5,500 |
| Director | ELDRED KARY | Dec 23, 2025 | Buy | $2.61K | 700 |
| Director | ELDRED KARY | Dec 23, 2025 | Buy | $2.61K | 700 |
| Chief Medical Officer | Jamil Khurram | Dec 17, 2025 | Sell | $31.53K | 4,479 |
| CEO | LEWIS JOEL | Dec 17, 2025 | Sell | $55.24K | 7,829 |
| Director | Shlevin Harold H. | Dec 17, 2025 | Sell | $139.3K | 19,793 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.